Apellis Pharmaceuticals shares owned by Goodman & Company, Investment Counsel
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Goodman & Company, Investment Counsel
from 13F filings
Historical chart of Goodman & Company, Investment Counsel investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Goodman & Company, Investment Counsel consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Apellis Pharmaceuticals by Goodman & Company, Investment Counsel
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $60M | 662k | 91.10 |
| 2023-03-31 | $8.6M | 131k | 65.96 |
| 2022-09-30 | $6.0M | 88k | 68.30 |
More positions owned by Goodman & Company, Investment Counsel
View all positions for Goodman & Company, Investment Counsel